- Home
- YJ vs CLDI Comparison
YJ vs CLDI Comparison
Compare YJ & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YJ
- CLDI
- Stock Information
- Founded
- YJ 2015
- CLDI 2014
- Country
- YJ China
- CLDI United States
- Employees
- YJ N/A
- CLDI N/A
- Industry
- YJ Other Specialty Stores
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- YJ Consumer Discretionary
- CLDI Health Care
- Exchange
- YJ Nasdaq
- CLDI Nasdaq
- Market Cap
- YJ 9.3M
- CLDI 8.7M
- IPO Year
- YJ 2019
- CLDI N/A
- Fundamental
- Price
- YJ N/A
- CLDI $1.60
- Analyst Decision
- YJ
- CLDI
- Analyst Count
- YJ 0
- CLDI 0
- Target Price
- YJ N/A
- CLDI N/A
- AVG Volume (30 Days)
- YJ 21.8K
- CLDI 142.9K
- Earning Date
- YJ 11-20-2025
- CLDI 11-11-2025
- Dividend Yield
- YJ N/A
- CLDI N/A
- EPS Growth
- YJ N/A
- CLDI N/A
- EPS
- YJ N/A
- CLDI N/A
- Revenue
- YJ $47,760,127.00
- CLDI N/A
- Revenue This Year
- YJ N/A
- CLDI N/A
- Revenue Next Year
- YJ N/A
- CLDI N/A
- P/E Ratio
- YJ N/A
- CLDI N/A
- Revenue Growth
- YJ N/A
- CLDI N/A
- 52 Week Low
- YJ $1.37
- CLDI $1.41
- 52 Week High
- YJ $2.67
- CLDI $46.68
- Technical
- Relative Strength Index (RSI)
- YJ 68.81
- CLDI 44.27
- Support Level
- YJ $1.93
- CLDI $1.41
- Resistance Level
- YJ $2.67
- CLDI $1.68
- Average True Range (ATR)
- YJ 0.13
- CLDI 0.08
- MACD
- YJ 0.02
- CLDI 0.05
- Stochastic Oscillator
- YJ 44.18
- CLDI 70.48
About YJ Yunji Inc. American Depository Shares
Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in the PRC.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.